On July 18, 2025, Abbott Laboratories (ABT, Financial) experienced a positive shift in analyst sentiment. Jefferies, a renowned financial services company, upgraded Abbott Laboratories' stock rating from "Hold" to "Buy". This change reflects increased confidence in the company's future performance.
The analyst behind this upgrade, Matthew Taylor, also adjusted the price target for Abbott Laboratories. The new price target has been raised from $143.00 to $145.00 USD, marking a 1.40% increase. This adjustment underscores the expectation of improved financial outcomes or strategic advancements by the company.
These updates from Jefferies, particularly regarding the stock ticker ABT, are noteworthy for investors and market participants keeping a close watch on Abbott Laboratories. With the current price target set at $145.00 USD, investors might perceive enhanced potential for upside in the stock.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 24 analysts, the average target price for Abbott Laboratories (ABT, Financial) is $143.05 with a high estimate of $159.00 and a low estimate of $120.12. The average target implies an upside of 18.71% from the current price of $120.51. More detailed estimate data can be found on the Abbott Laboratories (ABT) Forecast page.
Based on the consensus recommendation from 29 brokerage firms, Abbott Laboratories's (ABT, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Abbott Laboratories (ABT, Financial) in one year is $121.36, suggesting a upside of 0.71% from the current price of $120.51. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Abbott Laboratories (ABT) Summary page.
